Application of “Cloud Pharmaceutical Service System”in the medication therapy management for chronic airway diseases
- VernacularTitle:“云药事服务系统”在慢性气道疾病药物治疗管理中的应用
- Author:
Yinping SHI
1
;
Xue LIU
1
;
Xiangqian WANG
1
;
Sai DUAN
1
;
Yan LI
1
;
Xin HUANG
1
;
Rui YANG
1
Author Information
1. Dept. of Clinical Pharmacy，the First Affiliated Hospital of Shandong First Medical University （Shandong Provincial Qianfoshan Hospital）/Shandong Engineering and Technology Research Center for Clinical Evaluation and Development of Pediatric Drugs/Shandong Medicine and Health Key Laboratory of Clinical Pharmacy，Jinan 250014，China
- Publication Type:Journal Article
- Keywords:
Cloud Pharmacy Service System;
chronic
- From:
China Pharmacy
2023;34(7):878-882
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To evaluate the effect of “Cloud Pharmacy Service System” electronic management platform in medication therapy management （MTM） of chronic airway diseases. METHODS MTM module setting of “Cloud Pharmaceutical Service System” was introduced. Totally 371 patients with chronic airway disease admitted to our hospital from January 2021 to March 2022 were selected for MTM based on the “Cloud Pharmacy Service System”. The standardization of inhalation device mastery and compliance of patients before and after intervention were compared with self-made inhalation device evaluation scale and Morisky medication adherence scale-8 （MMAS-8）. The satisfaction of patients with pharmacist after intervention was investigated. RESULTS “Cloud Pharmaceutical Service System” is mainly divided into 4 modules， such as medication therapy review， pharmacist intervention， personal medication record and the medication-related action plan， other functions. Among 371 patients， there were 237 outpatients （142 cases of asthma， 95 cases of chronic obstructive pulmonary disease） and 134 inpatients （19 cases of asthma and 115 cases of chronic obstructive pulmonary disease）. The score of the patients using inhalation device increased from 74.76±24.71 before intervention to 99.45±2.12 after intervention （P＜0.05）. MMAS-8 score increased from 7.14± 1.15 before intervention to 7.88±0.44 after intervention （P＜0.05）. The degree of patients’ satisfaction with pharmacists reached 100% after intervention. CONCLUSIONS “Cloud Pharmacy Service System” is helpful to improve the effects of pharmaceutical service for patients with chronic airway disease by providing whole-process， online， visual and immediate MTM.
